Hint mode is switched on Switch off
For swift navigation between sections

Organization: Allergan plc
LEI 635400FWJZQC1IPYUH69, SWIFT AAGNIE2DXXX

Organization name
Allergan plc
Country name
Ireland
Country of registration
Ireland
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
2,290 mln USD

Find Any Data on Any Bond in Just One Click

Full data on over 800,000 bonds and stocks worldwide

Powerful bond screener

Ratings from the top 3 global ratings agencies, plus over 70 local ones

Over 300 pricing sources from the OTC market and world stock exchanges

Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Allergan, plc (formerly Actavis plc) is a global, integrated specialty pharmaceutical company. The Company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company produces and markets generic, branded generic, branded and over-the-counter (OTC) pharmaceutical products covering all therapeutic classes. The Company's product formulations include modified release, solid oral dosage, semi-solids, suspensions, transdermals, suppositories, creams, ointments, liquids and injectables.

Awards

News

02/06/2020 S&P Global Ratings withdrew Local Currency LT credit rating for Allergan
02/06/2020 S&P Global Ratings withdrew Foreign Currency LT credit rating for Allergan
14/05/2020 Fitch Ratings withdrew LT Int. Scale (foreign curr.) credit rating for Allergan
14/05/2020 Fitch Ratings upgrades LT Int. Scale (foreign curr.) credit rating of Allergan to "BBB" from "BBB-"; outlook positive
11/05/2020 S&P Global Ratings upgrades Foreign Currency LT credit rating of Allergan to "BBB+" from "BBB"; outlook stable
All organization news

Documentation

IFRS/US GAAP reports

2020
I q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide
Authorization required
You need to request access

Affiliates

Stocks

Latest issues

Show all

Bond debt by currency

Show more Hide

Codes

  • LEI
    635400FWJZQC1IPYUH69
  • SWIFT
    AAGNIE2DXXX
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • ICB
    4,500 Health Care
  • CIK
    0001578845

Credit and ESG Ratings

Macroeconomic Indicators - Allergan plc

Registration is required to get access.